Neurogene Nets ~$135 Million From Equity Offering; Underwriters Exercise Full Option
Neurogene entered into an underwriting agreement to sell 3,500,000 shares at $30.00 per share and pre-funded warrants for 666,666 shares at $29.999999 each. The underwriters exercised in full a 30-day option to purchase an additional 624,999 shares on July 1, 2026. Net proceeds are expected to be a…